Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Curr Opin Nephrol Hypertens. 2016 Mar;25(2):144–151. doi: 10.1097/MNH.0000000000000202

Figure 3.

Figure 3

Figure 3

(A) Serum creatinine, blood pressure and medications over an eight year period in a patient with unilateral atherosclerotic renovascular disease associated with a nonfunctioning kidney (less than 5% by renal scan). This patient developed severe hypertension that responded well to a regiment based upon an angiotensin receptor blocker (valsartan). Several years later, however, she developed worsening renal failure with an eGFR = 16 ml/min/1.73m2, leading to evaluation for kidney transplantation. Her disease was managed conservatively, but she developed severe hypertension and worsening renal function (creatinine above 5.0 mg/dL), leading her physician to withhold the ARB. Serum creatinine fell, although blood pressure was difficult to control and she developed episodes of acute pulmonary edema. (B) Doppler ultrasound identified a stenosis to her remaining functional kidney (peak systolic velocity above 500 cm/s). This was treated with endovascular stenting, with marked improvement in blood pressure levels, stable kidney function and tolerance to restarting the ARB (valsartan).